Fidelity International’s Bioceres Crop Solutions BIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,035
Closed -$6.29K 918
2024
Q4
$6.29K Hold
1,035
﹤0.01% 909
2024
Q3
$8.14K Hold
1,035
﹤0.01% 929
2024
Q2
$11.6K Sell
1,035
-1,692
-62% -$19.8K ﹤0.01% 889
2024
Q1
$34.5K Hold
2,727
﹤0.01% 814
2023
Q4
$37.4K Sell
2,727
-1,889
-41% -$22.1K ﹤0.01% 780
2023
Q3
$52.1K Buy
4,616
+1,303
+39% +$15.6K ﹤0.01% 742
2023
Q2
$44.3K Hold
3,313
﹤0.01% 747
2023
Q1
$38.5K Hold
3,313
﹤0.01% 776
2022
Q4
$39.9K Buy
3,313
+1,544
+87% +$20K ﹤0.01% 793
2022
Q3
$23K Buy
+1,769
New +$21.7K ﹤0.01% 807

Other funds holding BIOX

Fidelity International's BIOX Position: Q1 2025 in Review

Fidelity International sold out of Bioceres Crop Solutions (BIOX) in Q1 2025, closing a stake of 1,035 shares — an estimated $6.29K sold.

Fidelity International first reported a position in BIOX in Q3 2022 and held it in 10 quarters. The position peaked at $52.1K in Q3 2023. 38 funds tracked by Wall St. Rank hold BIOX as of Q1 2025.

  • Fidelity International reported no remaining Bioceres Crop Solutions position as of Q1 2025 after selling out during the quarter.
  • Fidelity International sold 1,035 Bioceres Crop Solutions shares in Q1 2025, an estimated $6.29K.
  • Fidelity International first reported a position in Bioceres Crop Solutions in Q3 2022 and held it in 10 quarters.
  • Fidelity International's Bioceres Crop Solutions position peaked at $52.1K in Q3 2023.
  • 38 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q1 2025.

Based on Fidelity International's 13F filing for Q1 2025, filed 12 May 2025.